Literature DB >> 8807366

Metastatic pancreatic neuroendocrine carcinoma causing Cushing's syndrome. ACTH secretion by metastases 3 years after resection of nonfunctioning primary cancer.

L Zhu1, D R Domenico, J M Howard.   

Abstract

CONCLUSION: Following resection of a nonfunctioning neuroendocrine carcinoma of the pancreas, subsequent metastases, in the absence of a primary cancer (resected), developed the capacity to secrete ACTH and create the Cushing syndrome.
BACKGROUND: Although neuroendocrine carcinomas of the pancreas may produce one or more hormones and may switch secretion to a different hormone, no report is identified of a metastasis, in the absence of the primary tumor, developing de novo the capacity to secrete ACTH.
METHODS: A nonfunctioning islet cell carcinoma was resected and immunochemically stained for multiple hormones. Three years later hepatic metastases were partially resected and stained as before.
RESULTS: The primary cancer stained negative for ACTH and cortisol, positive for serotonin, and focally positive for gastrin. Three years later, after the development of a florid Cushing syndrome, the metastasis stained strongly for ACTH and negative for serotonin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807366     DOI: 10.1007/BF02787369

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  12 in total

1.  Oat cell carcinoma in the pancreas: an unusual cause of Cushing's syndrome.

Authors:  M Sandler; P C Rubin; J L Reid; G D Smith
Journal:  Br J Hosp Med       Date:  1992 Apr 1-14

2.  A malignant insulinoma transformed into a glucagonoma syndrome.

Authors:  A Ohneda; M Otsuki; H Fujiya; N Yaginuma; T Kokubo; H Ohtani
Journal:  Diabetes       Date:  1979-11       Impact factor: 9.461

3.  Multiple hormone producing islet cell carcinomas of the pancreas. A morphological and biochemical investigation.

Authors:  S Hammar; G Sale
Journal:  Hum Pathol       Date:  1975-05       Impact factor: 3.466

4.  Pancreatic islet cell carcinoma with hyperinsulinism and probable, ectopic ACTH-MSH secretion.

Authors:  W V Vieweg; A L Graber; G M Cerchio
Journal:  Arch Intern Med       Date:  1969-12

5.  Pancreatic islet cell carcinoma producing gastrin, ACTH, alpha-endorphin, somatostatin and calcitonin.

Authors:  S L Asa; K Kovacs; D W Killinger; N Marcon; M Platts
Journal:  Am J Gastroenterol       Date:  1980-07       Impact factor: 10.864

6.  Suppression of ectopic adrenocorticotropin secretion by the long-acting somatostatin analog octreotide.

Authors:  X Bertagna; C Favrod-Coune; H Escourolle; P Beuzeboc; B Christoforov; F Girard; J P Luton
Journal:  J Clin Endocrinol Metab       Date:  1989-05       Impact factor: 5.958

7.  [Cushing syndrome in a neuroendocrine pancreatic tumor. Clinicopathologic case report].

Authors:  C Schneider; H O Mittelmeier; C Gebhardt
Journal:  Leber Magen Darm       Date:  1992-11

8.  Adrenocorticotropic hormone--secreting islet cell tumors: are they always malignant?

Authors:  J L Doppman; L K Nieman; G B Cutler; G P Chrousos; D L Fraker; J A Norton; R T Jensen
Journal:  Radiology       Date:  1994-01       Impact factor: 11.105

Review 9.  Pancreatic exocrine carcinoma producing adrenocorticotropic hormone.

Authors:  L Gullo; R De Giorgio; A D'Errico; W Grigioni; M Parenti; R Corinaldesi
Journal:  Pancreas       Date:  1992       Impact factor: 3.327

10.  Clinical and hormonal effects of a long-acting somatostatin analogue in pancreatic endocrine tumors and in carcinoid syndrome.

Authors:  J C Souquet; G Sassolas; J Forichon; P Champetier; C Partensky; J A Chayvialle
Journal:  Cancer       Date:  1987-05-01       Impact factor: 6.860

View more
  3 in total

1.  Tumor Lysis Syndrome in an Unusual Metastatic Pancreatic Neuroendocrine Tumor with Ectopic ACTH Secretion.

Authors:  Michael Shusterman; Noah A Bloomgarden; Susan T Sotardi; Aditi Shastri
Journal:  J Gastrointest Cancer       Date:  2016-12

2.  Hyperinsulinemic hypoglycemia associated with ectopic Cushing's syndrome due to a pancreatic endocrine tumor in a Type 2 diabetes mellitus patient: clinical implications of a rare association.

Authors:  M Filippella; M V Davì; G Doveri; E Lillaz; A Ciccarelli; E Massimetti; M Toaiari; M Falconi; A Colao; A Faggiano
Journal:  J Endocrinol Invest       Date:  2010-04-12       Impact factor: 4.256

Review 3.  Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment.

Authors:  Cynthia Ro; Wanxing Chai; Victoria E Yu; Run Yu
Journal:  Chin J Cancer       Date:  2012-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.